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Abstract
Introduction
Elevated blood lead levels (BLL) and malaria carry an important burden of disease in West
Africa. Both diseases might cause anemia and they might entail long-term consequences
for the development and the health status of the child. Albeit the significant impact of malaria
on lead levels described in Nigeria, no evaluation of the effect of elevated BLL on malaria
risk has been investigated so far.
Materials and Methods
Between 2010 and 2012, blood lead levels of 203 Beninese infants from Allada, a semi-
rural area 50km North from Cotonou, were assessed at 12 months of age. To assess lead
levels, blood samples were analyzed by mass spectrometry. In parallel, clinical, microbio-
logical and hematological data were collected. More precisely, hemoglobin, serum ferritin,
CRP, vitamin B12, folate levels, and Plasmodium falciparum parasitemia were assessed
and stool samples were also analyzed.
Results
At 12 months, the mean BLL of infants was 7.41 μg/dL (CI: 65.2; 83), and 128 infants (63%)
had elevated blood lead levels, defined by the CDC as BLL>5 μg/dL. Lead poisoning,
defined as BLL>10 μg/dL, was found in 39 infants (19%). Twenty-five infants (12.5%) had a
positive blood smear at 12 months and 144 infants were anemic (71%, hemoglobin<110 g/
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L). Elevated blood lead levels were significantly associated with reduced risk of a positive
blood smear (AOR = 0.38, P-value = 0.048) and P. falciparum parasite density (beta-esti-
mate = -1.42, P-value = 0.03) in logistic and negative binomial regression multivariate mod-
els, respectively, adjusted on clinical and environmental indicators.
Conclusion
Our study shows for the first time that BLL are negatively associated with malarial risk con-
sidering other risk factors. Malaria is one of the main causes of morbidity and mortality in
infants under 5 years worldwide, and lead poisoning is the 6th most important contributor to
the global burden of diseases measured in disability adjusted life years (DALYs) according
to the Institute of Health Metrics. In conclusion, due to the high prevalence of elevated BLL,
health interventions should look forward to minimize the exposure to lead to better protect
the population in West Africa.
Introduction
Elevated lead level has severe harmful effects on infant health. Symptoms related to toxicity
occur from mid to high levels of exposure and they depend on the amount of lead in the blood
and tissues. High lead levels are associated with impaired neurocognitive development, anemia
(due to either disruption of heme synthesis or hemolysis[1]), and renal and gastro-intestinal
effects[2]. Although high blood lead levels (BLL) (BLL>100 μg/dL) can entail acute neurologic
symptoms, such as ataxia, hyperirritability, convulsions, coma, and death, BLL as low as 10 μg/
dL have been also correlated with poor neurocognitive outcomes and behavioral disorders
[3,4]. This is of special concern in young children as neuro-cognitive impairment has been
found to be associated with the degree of exposure to lead between the ages of 12 and 36
months[5]. Indeed, the Center for Disease Control (CDC) reduced the reference level of blood
lead from 10 μg/dl to 5 μg/dl [6] in 2012.
Albeit the severe impact of elevated lead level on infant health, epidemiological studies of
lead level in Sub-Saharan Africa are limited. Data from the few existing studies, published in a
systematic review on BLL among Sub-Saharan children, suggest an alarming burden of ele-
vated BLL. This review reported a BLL weighted mean of 13.1 μg/dl which increased up to
16.2 μg/dl considering solely studies with robust quality BLL analyses[7]. In addition, the prev-
alence of BLL>10 μg/dL exceeded 44% in all cases reviewed, with a maximum of 70.9% in
Nigeria. Only one study in Kenya reported a relatively low prevalence (7%). Recent mass level
intoxications reported in Senegal and Nigeria[8] further raise the public health concern about
lead exposure in West Africa.
In addition, malaria and lead poisoning overlap geographically. Indeed, infectious diseases,
mainly malaria, dominate the disease burden in West Africa[9]. In Benin, malaria is the main
cause of mortality among children less than 5 years and there were over 1.5 million cases in
2012[10]. As already explained, both malaria and lead poisoning can have severe hematologic
and neurologic symptoms on children and their development. Malaria and lead poisoning may
not only overlap, but they have major impact on the health of children, especially those under
5 years. Consequently, their possible association may have an effect on one of the most vulnera-
ble age groups in the population, and it could have severe long-term implications for the devel-
opment of the children. Furthermore, Nriagu found a significant effect in univariate analysis of
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malaria on the children lead levels in different areas of Nigeria[11]. However, this article refers
only to malaria episodes recalled by the children or their family during the previous 6 months
and no biological evaluation of malaria is conducted in his study. Furthermore, malaria is not
included in the multivariate analysis of factors associated with BLL. Indeed, no accurate evi-
dence exists at present on the possible joint effect of lead and P.falciparum. To our knowledge,
no published study exists on lead levels in Benin, and in particular, on the effects of lead levels
on malaria risk in infants. Therefore we aim at analyzing the effect of lead levels on malaria risk
with regard to both the possibility of having a positive smear and their effect on P.falciparum
parasite density taking into account hematological and parasitological factors.
Materials and Methods
Our cross-sectional study used data obtained from two-hundred and three infants at 12
months of age. These infants were followed from birth until 12 months of age in two embedded
studies: the APEC study (Anemia in Pregnancy: Etiology and Consequences) and the TOVI
study. The TOVI study evaluated the children for cognitive and motor functions using the
Mullen Scales of Early Learning as well as their lead levels at 12 months[12]. The APEC study
involved a prospective cohort of 400 infants followed from birth to 12 months of age to assess
their health status. The follow-up of the APEC study was mainly focused on the malarial and
hematologic status of the infants. Indeed, malaria detection was performed systematically at
birth, at 6, 9, and 12 months of age. In addition, passive case detection was performed continu-
ously during follow-up. Malaria history of their mothers during pregnancy is well described in
an article already published[13]. The 203 infants of our sample correspond to the infants for
whom data at 12 months include a complete follow-up of lead and malaria indicators.
For further details, APEC study is an ancillary survey nested within the MiPPAD study in
Benin (Malaria in Pregnancy Preventive Alternative Drugs “http://clinicaltrials.gov/ct2/show/
NCT00811421”). This study was conducted in three clinics in the district of Allada (Allada,
Attogon, Sékou), between January 2010 and May 2012. Allada is a semi-rural area of 91,778
inhabitants located 50 km North of Cotonou (Benin). Malaria has a perennial transmission
pattern with two transmission peaks corresponding to the rainy seasons in April-July and
October-November. Plasmodium falciparum is the species responsible for the majority of
infections.
At 12 months, clinical data of the infants were collected, including anthropometric mea-
sures and clinical examination. Weight was measured using an electronic baby scale (SECA
type 354) with a precision of 10 g and length was measured to the nearest 1 mm with a locally
manufactured wooden measuring scale according to the criteria recommended by WHO. Eight
milliliters (mL) of venous blood were obtained from each participant. Hemoglobin, serum fer-
ritin, CRP, vitamin B12, lead and folate levels were thereby assessed. A container was also
given to the women to collect stools to examine the presence of intestinal helminths in the
infants. Microbiological exams were realized as follows: Lambaréné technique was used to
assess malaria infection on thick blood smears [14]. It consists of spreading a calibrated 10 μL
amount of blood on a slide’s rectangular area of 1.8 cm2 (1.8 x 1 cm). The slide was stained
with Giemsa and read at a magnification of 1,000 × with an oil immersion lens. To assess para-
site density (in parasites/μL), a multiplication factor was applied to the average parasitaemia/
field. Helminthic infestations were assessed using the Kato-Katz concentration method (Ves-
tergaardFrandsen kit1). The hemoglobin level was measured with a Hemo-Control photome-
ter (EKF Diagnostics, Magdeburg, Germany) device. Serum ferritin, folic acid, and vitamin B12
concentrations were measured using a microparticle enzyme and fluorescence polarization
immunoassay (AxSym Immuno-Assay Analyzer, Ab- bott Laboratories). CRP concentration
Association of Blood Lead Levels with Malaria in Infants in Benin
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was determined by rapid slide test (CRP Latex; Cypress Diagnostics Inc.) to correct the effect of
inflammatory syndromes on ferritin concentrations. More precisely, we corrected serum ferri-
tin in the context of inflammation following the procedure inspired by the meta-analysis by
Thurnham[15] before conducting the analyses, so we multiplied serum ferritin by 0.76 in the
presence of Plasmodia without inflammation, and we multiplied serum ferritin by 0.53 in case
of concurrent Plasmodia infection and inflammation. Iron deficiency was then defined as cor-
rected serum ferritin concentration<12 μg/l in infants. Iron deficiency anemia (IDA) was
defined as hemoglobin<110 g/l with iron deficiency.
With regard to BLL, 4 mL (out of the 8 ml obtained at 12 months) were collected into a tube
containing dipotassium EDTA and 4 mL into an iron-free dry tube. Blood samples were ana-
lyzed for lead using method M-572 of INSPQ’s Toxicology Laboratory, which is accredited ISO
17025 and participates in the QA/QC program of the Canadian Northern Contaminants Pro-
gram and the Arctic Monitoring Assessment Program. Briefly, samples were diluted 20-fold in
ammonia 0.5% v/v and 0.1% v/v Triton-X 100 and analyzed by inductively coupled plasma
mass spectrometry (ICP-MS; Perkin Elmer Sciex Elan DRC II ICP-MS instrument). The limit
of detection was 0.2 μg/L and inter-day precision was 7.5% at 14 μg/L. The samples were trans-
mitted by DHL frozen in icepacks directly from Cotonou to the University of Laval.
Preventive measures against malaria in the APEC study include insecticide treated bednets
(ITNs) and intermittent preventive treatment in pregnancy (IPTp). Infants were treated with
artemether-lumefantrine in the case of malaria according to Beninese guidelines.
Because of the anopheline breeding cycle, the mean rainfall volume of the 7 days prior to
the two weeks before the consultation was calculated. It was independently assessed for each
health centre of the district of Allada.
Socio-economic status was assessed using a socio-economic index created in a two-step pro-
cess. First all socio-economic items (home possession of latrines, electricity, a refrigerator, a
television, a vehicle with at least two wheels, being married, and working outside the home)
were plotted into a multiple correspondence analysis[16,17]. Then, two predictors were created
to synthesize the information, and as the first captured the large majority of the information, it
was withheld as the socio-economic index. We used this approach because it allows us to create
a synthetic objective index of socio-economic items without any a priori on the weight of each
of the elements of the index.
Statistical analysis
Data were double entered and analyzed with ACCESS2003 and STATA12.0 softwares for Win-
dows (Stata Corp, College Station, TX, USA). Univariate analysis was performed to assess the
association of all variables with either the infant positive smear or peripheral P.falciparum den-
sity at the moment of lead assessment (at 12 months of age). Thereafter, all variables with P
values<0.2 were included in a multivariate model regression. Logistic regression was used to
evaluate the determinants associated with a positive blood smear. Negative binomial regression
was used for the multivariate analysis of P.falciparum parasite density. Lead level was analyzed
as a variable with different categories as there is no linear relationship between parasite density
and lead levels. Socio-economic status was forced into the model because of its known associa-
tion with lead levels according to the literature[11]. The statistical significance in the final mul-
tivariate models was set to P<0.05.
Ethical considerations
This study and the consent procedure regarding the women and their offspring were approved
by the Ethics Committee of the Faculty of Medicine of Cotonou, Benin. It was explained in
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local language to the participant and her voluntary written consent was obtained and recorded
in the clinic files before enrolment. In case the woman could not read, an impartial witness was
included in the process. In the case of the inclusion of minor women, both their consent and
the consent from the parents or legal guardians were obtained. Women were free to interrupt
their participation at any time of the study. In addition, the study was also approved by the eth-
ics committee of the New York University, in the context of the NIH funding of the TOVI
study.
Results
The BLL of 203 infants included in the APEC-cohort were obtained at the 12-month visit
between April 2011 and May 2012. During the 12-month follow-up 84 infants (42%) had at
least one malarial episode. More precisely, 60.25% of infants had no positive blood smear dur-
ing the entire follow-up period, 22% of infants had 1, 12.50% had 2, 4.5% had 3, and 0.75% had
4 positive blood smears during follow-up. The main demographic, malarial and hematological
indicators as well as lead levels are presented in Table 1. There was a majority of girls, and, on
average, the infant’s weight was 8.44 kg and their height was 72.56 cm. This corresponds to a
small weight for height index compared to WHO standards. There were 76 infants excluded
during the 12-month follow-up, including 5 lost of follow-up (Fig 1). There were no differences
with regard to malaria risk and the characteristics at enrolment between the infants excluded
and the infants that completed the follow-up. In addition, multiple imputation technique was
used and results did not differ significantly.
At the moment of lead assessment, 25 out of 200 (12.5%) of the infants had a positive blood
smear, with a mean parasite density of 13460 (CI: 2775; 24145). Lead levels were high overall.
The mean BLL of infants was 7.41 μg/dL (CI: 65.2; 83), and 128 infants (63%) had elevated
blood lead levels, defined by the CDC as BLL>5 μg/dL. Lead poisoning, defined as BLL>10 μg/
dL, was found in 39 infants (19.21%). The distribution of blood lead levels is presented below
(Fig 2). More concretely, it corresponds roughly to a approximately to a shape of a log-normal
distribution. The lead distribution function can be divided in 4 quartiles that gather the differ-
ent BLL values of the infants. The minimum of the function corresponds to an infant with BLL
at 0.83 μg/dL and the infant with the highest BLL has 58.7 μg/dL. More precisely, the 1st quar-
tile includes infants with BLL between 0.83–3.9 μg/dL, the 2nd quartile includes infants with
Table 1. Demographic and clinical characteristics of the infants.
Parameters Mean or number of people affected
Gender Male: 96 (48.48%), Female: 102
(51.52%)
Weight (g) 8437.25 (CI:8285.02; 8589.48)
Height (cm) 72.56 (CI: 72.04; 73.06)
Malaria infection (%) 25 (12.5%)
P.falciparum density (parasites/μL only for infants with positive
smears)
13460 (CI:2775; 24145)
Blood lead levels (μg/L) 74.1 (CI: 65.2;83)
Elevated blood lead levels (BLL>5 μg/dL) 128 (63.05%)
Lead poisoning levels (BLL>10 μg/dL) 39 (19.21%)
Haemoglobin (g/L) 101.69 (CI: 99.51; 103.86)
Anaemia (Hb <110 g/L) 144 (70.94%)
Ferritin (mg/L) 571 (CI: 429.67; 712.34)
Iron deﬁciency (corrected SF <15 μg/L) 85 (42.93%)
doi:10.1371/journal.pone.0149049.t001
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BLL between 3.9–5.8 μg/dL, the 3rd quartile includes infants with BLL between 5.8–8.7 μg/dL,
and the 4th quartile includes infants with BLL between 8.7–57.8 μg/dL.
With regard to the hematological indicators, 144 infants were anemic (70.94%,
hemoglobin<110 g/L), and 85 were iron deficient (42.93%, CRP-corrected serum ferritin (SF)
Fig 1. Infant follow-up.
doi:10.1371/journal.pone.0149049.g001
Fig 2. Distribution of the infant blood lead levels at 12 months.
doi:10.1371/journal.pone.0149049.g002
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<15 μg/L). The mean and median hemoglobin and ferritin values were 101.69 g/L and 104 g/L
(CI: 99.51; 103.86), and 571 mg/L and 201.5 mg/L (CI: 429.67; 712.34), respectively.
In both univariate and multivariate analyses, malaria risk and parasite density were treated
as the dependent variables. Weight, height, temperature, hemoglobin, serum ferritin, CRP,
vitamin B12, folate, blood lead levels, helminthic infestations, socio-economic status, and rain
volume were included in the analyses as independent variables and considered in both
analyses.
At 12 months, ferritin, vitamin B12 and CRP levels as well as low socio-economic status
were associated in univariate analysis with increased malaria risk with regard to both the risk
of having a positive smear and P. falciparum parasite density (Table 2). Rain volume was bor-
derline associated with malaria risk (p-value = 0.06). In parallel, hemoglobin and lead levels
were inversely correlated with malaria risk in univariate analysis. For both univariate and mul-
tivariate analyses all variables measured in the TOVI and the APEC study, described in the
methods section, were considered. Only statistically significant variables or variables important
for malaria risk according to literature (in this case the socio-economic status) were kept in the
final models.
There were no statistical significant differences in malarial, lead, or hematologic indicators
depending on the health care centre. Tables 3 and 4 describe risk factors associated with the
possibility of having a positive blood smear and high P.falciparum parasitaemia with lead levels
classified in quartiles, whereas Tables 5 and 6 refer to the possibility of having elevated BLL.
In multivariate analysis, high lead levels were significantly associated with reduced risk of a
positive blood smear and P. falciparum parasite density in logistic and negative binomial
regression models, respectively. More precisely, infants with BLL in the 3rd and 4th quartile
were significantly less likely to have a positive blood smear at 12 months (OR = 0.24, p-value =
0.05, and OR = 0.19, P-value = 0.04, respectively). Indeed, no positive blood smear was found
Table 2. Univariate analyses of variables associated with malaria risk at 12 months.
Variables p-value
Blood lead levels 0.001
Hemoglobin 0.001
Ferritin 0.01
Low socio-economic status 0.01
CRP 0.045
Vitamin B12 0.05
Rain volume 0.06
doi:10.1371/journal.pone.0149049.t002
Table 3. Logistic regression on the possibility of having a positive blood smear at 12 months.
Factor AOR (95% CI) p-value
Blood lead levels (BLL; μg/L) (1st quartile = reference)
BLL in the 2nd quartile 0.66 (0.22; 2.03) 0.47
BLL in the 3rd quartile 0.24 (0.06; 1.00) 0.05
BLL in the 4th quartile 0.19 (0.04; 0.95) 0.04
Ferritin levels (ferritin (mg/L) corrected on inﬂammation) 1.00 (1.00; 1.01) 0.03
Vitamin B12 (ng/mL) 0.99 (0.99; 1.00) 0.5
Low socio-economic status 1.81 (1.07; 3.07) 0.03
Prob>chi2 = 0.0002 Number of observations = 197
doi:10.1371/journal.pone.0149049.t003
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among infants with lead poisoning. With regard to Plasmodium falciparum parasitemia,
infants with BLL in the 3rd and 4th quartile were significantly less likely to have a high parasite
density at 12 months (beta coefficient = -2.3, p-value = 0.03, and beta coefficient = -2.1, P-
value = 0.03, respectively). Furthermore, infants with elevated BLL (i.e. BLL> 5 μg/ dL,
Table 4) were significantly less likely to have a positive blood smear and a high P. falciparum
density (AOR = 0.38 95% CI (0.15; 0.99), and beta coefficient = -1.42, P-value = 0.05, respec-
tively). Factors associated with increased malaria risk include also high iron levels. In effect, ele-
vated ferritin levels corrected on inflammation were associated with increased risk of a positive
blood smear, also in the analysis of elevated lead levels (Table 5). In addition, low socio-eco-
nomic status was also statistically associated to an increased malaria risk (AOR = 1.81, P-value
= 0.03; Table 3).
Adjustments on known prognostics factors for malaria were included in the models to
avoid potential confounders. However, they were not statistically significant and, consequently,
they have been removed from the final model.
Discussion
The high proportion of infants with elevated BLL (63%) and lead poisoning (19%) plead for
the necessity of considering the possible influence of lead levels on the infant infectious mor-
bidity, especially with regard to malaria, the main cause of mortality in children<5 years. In
Table 4. Negative binomial regression on factors associated with P.falciparum density (logarithm of parasite density at lead assessment).
Factor Coefﬁcient (95% CI) p-value
Blood lead levels (BLL) (1st quartile = reference)
BLL in the 2nd quartile -1.18 (-2.99; 0.64) 0.20
BLL in the 3rd quartile -2.30 (-4.43; -0.18) 0.03
BLL in the 4th quartile -2.10 (-4.00; -0.23) 0.03
Low socio-economic status 0.60 (-0.04; 1.24) 0.06
Number of observations = 197
doi:10.1371/journal.pone.0149049.t004
Table 5. Logistic regression on the possibility of having a positive blood smear at 12 months.
Factor AOR (95% CI) p-value
Elevated blood lead levels (BLL>5 μg/dL) 0.38 (0.15; 0.99) 0.048
Ferritin levels 2.86 (1.13; 7.27) 0.03
(logartihm of the ferritin (mg/L) corrected on inﬂammation)
Low socio-economic index 1.42 (1.2; 7.93) 0.16
Inﬂammatory process (CRP levels 5 mg / mL) 3.09 (1.2; 7.93) 0.02
Prob>chi2 = 0.0005 Number of observations = 197
doi:10.1371/journal.pone.0149049.t005
Table 6. Linear regression on factors associated with P.falciparum density at 12 months (logarithm of
parasite density at lead assessment).
Factor Coefﬁcient (95% CI) p-value
Elevated blood lead levels (BLL>5 μg/dL) -1.42 (-2.83; -0.02) 0.03
Low socio-economic index 0.43 (-0.16; 1.02) 0.15
Prob> = chibar2 = 0.00 Number of observations = 197
doi:10.1371/journal.pone.0149049.t006
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effect, high BLL were significantly associated with reduced malaria risk with regard to both the
possibility of having a positive blood smear and P. falciparum density. Concern has been
repeatedly raised up on the importance of alarmingly high anemia rates in West Africa[18],
and both malaria and elevated BLL are associated with increased anemia rates.
Similar prevalence of elevated BLL has been found in other West-African regions. The
mean BLL value for this study (7.4 μg/dL) is slightly lower than the mean BLL found by Nriagu
et al in Nigeria in 2008[11] (8.9 μg/dL). In Jos, Nigeria, another study reported an average BLL
of 11.2 μg/dL (range: 9.1–13.3 μg/dL), and that 55% had BLLs above 10 μg/dL[19]. Indeed, the
existing epidemiological evidence reveals the high prevalence of elevated BLL among African
infants. However, there is very limited evidence on their effect on malaria. Nriagu et al
described the inverse association of BLL and malaria in univariate analysis (P-value =<0.001).
Our results not only ascertain this association in univariate analysis, but they evidence the sig-
nificant association of BLL with malarial risk taking into account complementary malaria risk
factors. These results show that elevated BLL are also associated with reduced probability of a
positive blood smear as well as reduced P.falciparum parasite density. As a consequence, epide-
miological evidence in our study rejects the possible synergistic effect of lead on P.falciparum
infection, but rather suggests a protective effect. In addition, the high BLL present in our sam-
ple raise concern on their possible harmful consequences for the infant health.
Indeed, sources of lead should be further investigated to implement public health policies
targeting the reduction of the exposure to lead. In our case of study, sources of lead may include
paint, piped water, leaded gazoline or consumption of animals killed by ammunition. These
hypotheses are currently under study.
The mechanism by which lead might influence malaria infection has not been elucidated so
far. However, Nriagu postulated that there are multiple levels at which lead can modulate the
specific host response to Plasmodium infection including alterations in heme synthesis, immu-
noregulation, and iron metabolism.
Lead concentrates in red blood cells (RBC) in the context of lead poisoning[20]. The accu-
mulation of lead in the RBC may inhibit the development of the parasite. Elevated intra-eryth-
rocytic concentration of lead may interfere with the development from the ring form to the
schizont stage and, consequently, lead exposure may be associated to reduced parasitemia in
malaria-infected infants.
In addition, elevated BLL can exert a general effect on the immune regulatory function
[21,22]. In this respect, both lead poisoning and malaria favor the cytokine response which, in
turn, has an influence on the Th1/Th2 balance[23,24]. Indeed, a certain protection against
severe malaria has been described as a consequence of the Th2 response following the alter-
ation of the immune system induced by lead poisoning[25].
Alternatively, iron deficiency and hemoglobinopathies can foster the anti-parasite effect of
lead in the context of the blood stages of P. falciparum. Indeed, iron deficiency may interfere
with the proper use of iron by the parasite[26]. However, iron deficiency was not significantly
correlated with malaria risk in our analyses. Finally, high intra-erythrocyte lead concentration
can inhibit protein synthesis[27], and thereby interfere with the correct iron utilization by Plas-
modia[26].
With regard to iron levels, high iron levels have already been associated with increased
malaria morbidity[28]. This raises the concern on the iron supplements recommended by the
WHO when anemia prevalence>40%, which is the case of Benin. Iron deficiency has fre-
quently been linked to a certain protection against malaria[29]. Nevertheless, results on the
effect of iron levels on malaria differ in the context of clinical trials with iron supplements. In
a specific Cochrane review[29] no significant difference in clinical malaria episodes was
detected between children supplemented with iron alone and those receiving a placebo (risk
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ratio (RR) = 0.99, 95% CI (0.90; 1.09). However, solid preventive measures against malaria
were implemented in the clinical trials. Moreover, an increased risk of malaria with high iron
levels was observed in trials that did not provide malaria surveillance and treatment, and the
risk of malaria parasitaemia was higher with high iron levels (RR = 1.13, 95% CI (1.01; 1.26)
[29]. Furthermore, published literature reports both iron and lead have a significant effect not
only on malaria, but also on anemia. Indeed, strategies to tackle anemia should consider not
only iron supplementation but, as said, public health policies should also imply the sources of
elevated BLL.
Our study is subjected to certain limitations. In a cross-sectional design one can only find
evidence of associations. Our hypothesis is that high lead levels may reduce malaria risk. But
the sense of the association might be set into question. However, reverse causality seems
unlikely. Malaria entails anemia, and this should facilitate the absorption of lead, while our
results show the opposite. Another limit of cross-sectional designs is that they do not allow the
study of temporality. As a consequence, this association should be further studied in the con-
text of a prospective longitudinal follow-up with repeated measures. Indeed, it would be inter-
esting to analyze the evolution of the association through infancy. In conclusion, exposure to
lead can in no way be considered as a potential method to prevent malaria in children. There-
fore, public health interventions should look forward to minimize infant exposure to lead by all
possible means, along with a reinforcement of malaria preventive interventions among the
pediatric population.
Conclusion
In conclusion, our study shows that BLL are negatively associated with malarial risk consider-
ing other risk factors. Malaria entails high morbidity and mortality rates among infants under
5 years worldwide[10], and lead poisoning is the 6th most important contributor to the global
burden of diseases measured in disability adjusted life years (DALYs) according to the Institute
of Health Metrics, with Sub-Saharan African countries being predominantly responsible for
the global DALYs[30]. Our study shows very high rates of EBLL in young infants (12 months).
This should raise the awareness of public health authorities to further evaluate the sources and
the epidemiological consequences for infants. Lead poisoning entails severe consequences for
the development of the children and is associated with major health problems highly prevalent
in West Africa, such as anemia and under-nutrition, having an important impact on the infants
and their communities. In addition, our study is the first to show a negative association
between lead levels and malaria risk in multivariable analyses. Therefore, these results should
be confirmed in the context of a prospective cohort. Furthermore, the social and financial con-
sequences of EBLL and lead poisoning appeal to further explore the epidemiological evidence
of the association of EBLL with communicable diseases in developing countries. Finally, public
health interventions should look forward to minimize the exposure to lead. Therefore, it is cru-
cial to investigate the lead sources to better protect the population in West Africa.
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